Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease

Journal Article · · Structure

Research Organization:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Organization:
~OTHER
DOE Contract Number:
SC0012704
OSTI ID:
1812476
Report Number(s):
BNL-221980-2021-JACI
Journal Information:
Structure, Vol. 29, Issue 8
Country of Publication:
United States
Language:
English

References (27)

PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain journal July 2002
Remdesivir for the Treatment of Covid-19 — Final Report journal November 2020
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design journal April 2020
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities journal November 2020
Origin and evolution of pathogenic coronaviruses journal December 2018
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease journal April 2020
Coronaviruses Resistant to a 3C-Like Protease Inhibitor Are Attenuated for Replication and Pathogenesis, Revealing a Low Genetic Barrier but High Fitness Cost of Resistance journal August 2014
Features and development of Coot journal March 2010
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 journal October 2020
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 journal October 2020
XDS journal January 2010
The Architecture of SARS-CoV-2 Transcriptome journal May 2020
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals journal December 2020
Identification of mutation resistance coldspots for targeting the SARS‐CoV2 main protease journal March 2021
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site journal November 2020
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease journal June 2020
Phaser crystallographic software journal July 2007
Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease journal February 2021
Collaboration gets the most out of software journal September 2013
SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model journal February 2021
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L journal November 2020
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning journal February 2021
The SARS-CoV-2 main protease as drug target journal September 2020
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor journal October 2003
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations journal February 2021
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors journal March 2020